Hospinvest, the former operator of the Hungarian state-owned hospitals, which is currently in the process of being liquidated, has not yet repaid its debts of HUF 3bn (€11.1m). According to the liquidator of the company, the repayment has not been made because Hungary’s National Health Insurance Fund (OEP) transferred money for the funding of the hospitals to the new operator instead of Hospinvest. Legal action was taken against OEP by Hospinvest, and the case continues. However, the outstanding amount could cover only wages and supplier payments, but not the repayments due to the bank.
Hospinvest, which was established in 2000 for the private operation of Hungarian hospitals, has been in the process of liquidation since mid-2009. The company declared itself bankrupt after its credit bank, CIB, used funds transferred to HospInvest by the OEP for healthcare services to repay debts. We have covered this matter on several occasions in Central Europe Pharma News.
1 year subscription to internet service providing market news and analytical articles
Central Europe Pharma Online provides news, articles and market data on the pharmaceutical market in Bulgaria, Czech Republic, Hungary, Romania, Poland and Slovakia, from manufacturers and distributors to medical devices and research developments. Over 70 industry updates, covering manufacturers and distributors, medical news and research developments, together with news on laws and regulations governing the pharmaceutical sector are added on a regular basis. For timely news delivery, custom newsletters can be sent directly to your e-mail account, with content personalisation.
Subscription 1 year
Language: English
Delivery: online access
12-month subscription (26 issues of biweekly news)
Central Europe Pharma News is a bi-weekly newsletter delivered in PDF format directly to your inbox. Each edition of the newsletter delivers news and analysis of the pharmaceutical sector in Bulgaria, Czech Republic, Hungary, Romania, Poland and Slovakia, including an in-depth feature on the pharmaceutical industry in the Central & Eastern Europe region written by PMR market analysts. A list of upcoming events relevant to the region and a company index are included in every issue.
Date: Periodic publication
Language: English
Delivery: PDF file
PMRis a British-American company providing market information, advice and services to international businesses interested in Central and Eastern Europe as well as other emerging markets. PMR key areas of operation include business publications (through PMR Publications), consultancy (through PMR Consulting) and market research (through PMR Research). Being present on the market since 1995, employing highly skilled staff, offering high international standards in projects and publications, providing one of most frequently visited and top-ranked websites, PMR is one of the largest companies of its type in the region.
PMR Online Access
Browse and search in our archive »
Subscribe to PMR RSS NEWS channels » 
